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Abstract The intracellular localization and activity of the nitric
oxide synthase (NOS) isoforms were investigated in rat brown
adipocytes. Immunohistochemistry showed cytoplasmic and
nuclear staining for the endothelial NOS (eNOS) and inducible
NOS (iNOS) isoforms; accordingly, anti-L-citrulline antibody, a
marker of NOS activity, immunostained both the cytoplasm and
the nucleus. The presence of metabolically active NOS in the
nucleus was further confirmed by immunoblotting analyses of
subcellular fractions of homogenates from cultured brown
adipocytes and by measurements of NOS activity in the cytosol
and nucleus. Sympathetic stimulation in vivo (i.e. cold exposure
or L3-adrenergic agonist treatment) and in vitro (i.e. noradrena-
line treatment of cultured cells) significantly increased both
cytosolic and nuclear eNOS and iNOS expression and
activities. By contrast, the number of iNOS-positive, but not
eNOS-positive, nuclei was significantly lower in the functionally
impaired brown fat of genetically obese Zucker fa/fa rats. These
data suggest the existence of a noradrenaline-modulated
functional NOS system in the nucleus of brown adipocytes.
ß 2002 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
In mammals, brown adipose tissue (BAT) is a strategically
located tissue whose primary function is to disperse the energy
contained in lipids as heat (non-shivering thermogenesis) [1,2].
The thermogenic activity of brown adipocytes is due to the
presence in mitochondria of a speci¢c protonophoric protein,
uncoupling protein 1 (UCP1) [3], and is triggered by nor-
adrenaline (NA), which is released from the sympathetic
nerves and acts mainly via L3-adrenoceptors in brown adipo-
cytes [1,2,4].
Nitric oxide (NO) is a gaseous messenger molecule that has
paracrine and autocrine functions [5^7]. Three NO synthase
(NOS) isozymes have been well characterized so far: the
Ca2/calmodulin-dependent endothelial NOS (eNOS) and
neuronal NOS (nNOS) isoforms and the Ca2/calmodulin-in-
dependent inducible NOS (iNOS) isoform [8]. In BAT, NO is
involved in the vasodilation that matches heat production
with tissue perfusion [9,10]. Of note, NA stimulates NO pro-
duction and release from cultured brown adipocytes, and
iNOS can be dynamically modulated in BAT in vivo since
acute cold exposure augments through increased NA output
[1,2,4] both iNOS mRNA and NOS activity [10].
Given that NO is a short-lived molecule that can di¡use
freely across biological structures but acts within a restricted
volume [11,12], the cellular and tissue localization of NOS
isoforms can provide crucial insights into the physiological
role of NO. We thus undertook an immunohistochemical
study of the distribution of the NOS isoforms in BAT. To
our surprise, we found eNOS- and iNOS-speci¢c staining in
the nuclei of brown adipocytes. This prompted us to design a
study to assess whether functional NOS systems could exist in
the nucleus of these cells and be modulated under conditions
of di¡erent functional activation.
2. Materials and methods
2.1. Animals and treatments
Six-week-old male Sprague^Dawley rats (Charles River, Calco,
Italy) were fed and housed in standard conditions (22‡C). Some re-
ceived the NOS inhibitors N-iminoethyl-L-lysine (L-NIL) and N-meth-
yl-L-arginine (L-NMMA; both from Sigma, Milan, Italy) for 2 days
(respectively, 3 and 30 mg/kg/day, i.p.) before immunohistochemical
evaluation. Some individually caged rats were acclimated to 4‡C for
3 or 14 days. Another group received 1 mg/kg/day of CL 316,243, a
selective L3-adrenoceptor agonist (kindly provided by K. Steiner,
Wyeth-Ayerst, USA), i.p. for 7 days. Finally, 6-week-old genetically
obese male Zucker rats (fa/fa) and their lean littermates (+/fa) were
obtained from Harlan Nossan (Corezzana, Italy).
2.2. Antibodies
Immunohistochemistry and Western blotting were performed using
two antibody sets: rabbit polyclonal antibodies against iNOS, eNOS
and nNOS (BioMol Research Laboratories, Plymouth Meeting, PA,
USA) and against L-citrulline (Arnel, New York, NY, USA), and
monoclonal antibodies against iNOS, eNOS and nNOS (Transduction
Laboratories, Lexington, KY, USA). We con¢rmed antibody specif-
icity in Western blot preparations from positive controls and BAT.
There were no di¡erences between the antibodies at Western blotting;
at immunohistochemistry, the polyclonal antibodies yielded better
speci¢c staining and less background.
2.3. Immunohistochemistry and morphometry
Rats were killed under i.p. anesthesia (100 mg/kg ketamine (Keta-
vet), Farm. Gellini, Aprilia, Italy, in combination with 19 mg/kg xy-
lazine (Rompun), Bayer AG, Leverkusen, Germany) and transcar-
dially perfused with 4% paraformaldehyde in 0.1 M phosphate
bu¡er, pH 7.4. Interscapular BAT was dissected and post¢xed over-
night in the same ¢xative by immersion. The samples were then dehy-
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drated and para⁄n-embedded. Immunoreactivity was assessed in 3-
Wm-thick serial sections using the avidin^biotin^peroxidase method as
already described [13]. To better appreciate negative nuclei, sections
were counterstained with hematoxylin. Negative controls were ob-
tained by omitting the primary antibody, using preimmune serum
instead of the primary antiserum and adsorbing the antibody with
an excess of antigen. Positive controls were: lipopolysaccharide
(LPS)-treated liver for iNOS, cerebellum for eNOS, and skeletal
muscle for nNOS. The antiserum against L-citrulline was raised
against a keyhole limpet hemocyanin conjugate of L-citrulline and
its speci¢city was evaluated in rat cerebellum [14]. The number of
iNOS- and eNOS-positive nuclei was morphometrically analyzed on
¢ve representative sections from three rats per experimental group. In
each section, we evaluated the percentage of positive nuclei vs. the
total number of brown adipocyte nuclei in ten randomly selected high-
power ¢elds.
2.4. Brown adipocyte culture and drug treatments
Brown fat precursor cells and intact brown adipocytes were isolated
as described previously [15] with some modi¢cations [10]. Cells were
exposed for 24 h to NA (1 WM, freshly diluted in bu¡ers containing
0.1% ascorbic acid) or tumor necrosis factor-K (TNF-K ; 10 nM) and
then harvested.
2.5. Cell fractionation and assay of NOS activities
The procedure for cell fractionation was as described previously
[16]. Cross-contamination of the nuclear fractions with other organ-
elles or cytosolic enzymes was evaluated by immunodetection of the
following markers: L-tubulin (monoclonal antibody, 1:500; Sigma),
Na,K-ATPase K1 subunit (monoclonal antibody, 1:500; kindly pro-
vided by Dr. G. Pietrini, Milan University, Italy) [17], ribophorin I
(Rib I, polyclonal antibody, 1:150; kindly provided by Prof. N. Borg-
ese, Catanzaro University, Italy) [18], cytochrome c oxidase subunit
IV (COX IV, monoclonal antibody, 1:5000; Molecular Probes, Eu-
gene, OR, USA), histone H1 (H1, monoclonal antibody, 1:500; Santa
Cruz Biotechnology, Santa Cruz, CA, USA).
Brown adipocyte eNOS and iNOS activities were estimated by mea-
suring the conversion of L-2,3,4,5-[3H]arginine to L-2,3-[3H]citrulline.
Ten million brown adipocytes, untreated or treated with 1 WM NA for
24 h, were homogenized using an Ultra-Turrax homogenizer (5 mm
blade) for 20 s in 0.5 ml of a bu¡er containing 50 mM HEPES, pH
7.4, 1 mM DL-dithiothreitol, 1 mM EDTA (for iNOS), 0.5 Wg/ml
leupeptin, 2 Wg/ml aprotinin, 0.7 Wg/ml pepstatin, and 1 mM phenyl-
methylsulfonyl £uoride. After centrifugation (12 000Ug for 20 min at
4‡C), an aliquot of the supernatant was added to the reaction mixture
to reach a ¢nal volume of 100 Wl containing 50 mM HEPES, pH 7.4,
50 nCi L-[3H]arginine (310 mCi/mmol; Amersham, Milan, Italy),
1 WM arginine, 1 mM NADPH, 10 WM CaCl2 (for eNOS), 1 mM
EDTA and 1 mM EGTA (for iNOS), 10 WM FAD, 0.1 mM (6R)-
5,6,7,8-tetrahydro-1-biopterin. The mixture was incubated at 37‡C for
various periods of time. The reaction was stopped by adding 0.4 ml of
a 1:1 slurry of Dowex AG 50W-X8 (Na form, Fluka, Milan, Italy)
in 50 mM HEPES, pH 5.5; supernatant radioactivity was measured
after 15 min of shaking. Enzyme activities were expressed as nmol of
citrulline formed by 1 mg of protein.
2.6. Western blotting
For eNOS and iNOS analyses, 50 and 100 Wg, respectively, of cell
fraction proteins were resolved through 8% SDS^polyacrylamide gel
electrophoresis under reducing conditions, and Western blotting was
performed as described previously [10]. Samples were densitometri-
cally quantitated with a Quick Image densitometer (Canberra, Pack-
ard, Milan, Italy) and a Phoretix 1D, version 3.0, software image
analyzer.
2.7. Data analysis
Data are reported as mean values þ S.E.M.; all the experiments
were performed at least three times, each time with three or more
independent observations. Comparisons were made using one-way
analysis of variance followed by Student^Newman^Keuls post hoc
comparisons; P values of 6 0.05 vs. the controls were considered
signi¢cant.
3. Results
3.1. eNOS and iNOS are located in brown adipocyte nuclei
In the animals kept at room temperature (22‡C), brown
adipocytes showed cytoplasmic staining with eNOS and
iNOS antibodies. Interestingly, and unlike the other positive
cell types in the tissue (endothelial cells of parenchymal capil-
laries and arteries, smooth muscle cells of large blood vessels
and some nerves), some brown adipocytes also showed spe-
Fig. 1. A: BAT eNOS immunohistochemistry (polyclonal antibody,
1:250). In rats kept at room temperature, some brown adipocytes
show speci¢c nuclear staining (arrows). Negative nuclei are also in-
dicated (arrowheads). Bar, 27 Wm. B: Immunoblotting analysis of
cell fractions obtained from cultured brown adipocytes and C2C12
cells (polyclonal antibody, 1:250). eNOS expression was studied in
homogenate (H), postnuclear supernatant (PNS) and nuclear (N)
fractions of cells treated or not (lanes 1^3 and 10^12) with NA (1
WM) or TNF-K (10 nM) (lanes 4^9).
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ci¢c nuclear staining for eNOS (Fig. 1A) and iNOS (not
shown). At 22‡C, weak cytoplasmic but no nuclear staining
was observed with nNOS antibodies. Positive controls (hepa-
tocytes and Kup¡er cells of LPS-treated rats for iNOS, skel-
etal muscle and aortic endothelium for eNOS, and cerebellum
granular layer neurons and glial cells for nNOS) exhibited the
expected cytoplasm staining.
The nuclear localization of the eNOS isoform was further
studied using subcellular fractionation, whereas cytosolic
(postnuclear supernatant, PNS) and nuclear fractions were
analyzed on immunoblot assays. The amount of protein in
the pellet and supernatant fractions loaded on the gel was
adjusted to correspond to the same number of cells. Both
nuclear and PNS fractions contained a polypeptide with an
apparent Mr of V140 kDa corresponding to eNOS (Fig. 1B,
lanes 1^3). Fraction purity was veri¢ed by Western blotting
with antibodies raised against markers for PNS (L-tubulin),
plasma membrane (Na,K-ATPase K1 subunit), endoplasmic
reticulum (Rib I), mitochondria (COX IV) and nucleus (H1)
(Fig. 1B).
Immunoblotting analysis of the C2C12 cell line, where
eNOS is expressed in large amount [19], showed that eNOS
was totally concentrated in the PNS, but was not found in the
nuclear fraction (Fig. 1B, lanes 10^12).
Both PNS and nuclear iNOS levels were below the detec-
tion threshold of Western blotting in unstimulated conditions.
The nNOS immunoblot con¢rmed the immunohistochemical
results, showing a very faint band in PNS but not in the
nuclear fraction (not shown).
3.2. eNOS and iNOS are functionally active in brown adipocyte
nuclei
To achieve the microscopic visualization of NOS catalytic
activity [20], we performed the immunolocalization of L-citrul-
line. Blood vessels and brown adipocytes were di¡usely
stained, the latter in the cytoplasm and/or nuclei. Pretreat-
ment of rats with L-NIL and L-NMMA, which speci¢cally
inhibit the activities of the inducible and endothelial NOS
isoforms, remarkably reduced both cytoplasmic and nuclear
staining for L-citrulline (not shown), thus also con¢rming the
speci¢city of the antibody. Immunohistochemical analysis of
serial sections showed that the brown adipocytes positive for
L-citrulline were also positive for eNOS (Fig. 2) or iNOS in
the cytoplasm and/or nucleus.
More direct evidence of the presence of the NOS isoforms
in cytosol and nuclei was obtained by measuring the conver-
sion of L-[3H]arginine to L-[3H]citrulline in cell fractions from
brown adipocytes di¡erentiated in culture. As shown in Fig.
3A, more than 35% of the Ca2-dependent (measured in 10
WM CaCl2-supplemented culture medium, without EGTA/
EDTA) and 15% of the Ca2-independent (1 mM EGTA/
EDTA, without CaCl2) enzyme activities in control cells
Fig. 2. eNOS (polyclonal antibody, 1:250) and L-citrulline (polyclonal antibody, 1:700) immunohistochemistry on BAT serial sections. At low
magni¢cation (left), the parenchymal ¢elds positive for eNOS are also positive for L-citrulline. At higher magni¢cation (right), both eNOS and
L-citrulline are found in the same cells and nuclei (arrows). * Capillary. Bar, 130 Wm (left) ; 20 Wm (right).
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were found in the nuclear fraction, and were only partially
lost in the absence of calcium. This strengthens the hypothesis
that total nuclear NOS activity can be ascribed to both the
Ca2-dependent (eNOS) (V69%) and the Ca2-independent
(iNOS) (V31%) isoforms (Fig. 3B).
3.3. The expression and functional activities of nuclear eNOS
and iNOS are modulated by NA both in vivo and in vitro
To gain further insights into the role of sympathetic activity
in the in vivo modulation of nuclear eNOS and iNOS expres-
sion and functional activity in brown adipocytes, BAT from
rats exposed to four di¡erent experimental conditions was
subjected to immunohistochemical analysis. In animals ex-
posed to 4‡C for 3 or 14 days, eNOS and iNOS cytoplasmic
staining was greater than in rats acclimated to room temper-
ature. Accordingly, the number of positive nuclei increased
progressively and peaked after 14 days (Table 1).
Cold-induced iNOS expression in rat BAT is mimicked by
L3-adrenoceptor stimulation of cultured brown adipocytes
[10]. To test the speci¢c involvement of L3-adrenoceptors,
lean rats acclimated at 22‡C were treated for 1 week with
CL 316,243 (1 mg/kg/day, i.p.), a selective thermogenically
active L3-adrenoceptor agonist [21]. Compared with saline-
treated rats, these animals showed a signi¢cantly higher num-
ber of nuclei positive for eNOS and iNOS (Table 1).
Finally, NOS isoform expression and intracellular localiza-
tion were analyzed immunohistochemically in BAT slices
from genetically obese (fa/fa) rats, in which BAT sympathetic
activity is markedly reduced [22,23]. In these animals, the
number of iNOS-immunostained nuclei was signi¢cantly low-
er than in normal-weight (+/fa) rats (22 þ 3% vs. 43 þ 4%; Fig.
4), whereas the number of eNOS-positive nuclei was the same
(47 þ 3% vs. 48 þ 4%).
Interestingly, immunostaining for L-citrulline (and for iNOS
Fig. 3. Ca2-dependent and -independent NOS activities in cultured brown adipocytes. A: Percentage of NOS activities in postnuclear superna-
tant (PNS) and nuclear (N) fractions of untreated cells, as measured by conversion of L-[3H]arginine to L-[3H]citrulline. B: Conversion of radio-
labeled L-arginine to L-citrulline in nuclear protein extracts from brown adipocytes di¡erentiated in culture treated (R, b) or not (O, a) with
NA (1 WM) at di¡erent times and in the presence (O, R) or absence (a, b) of calcium (10 WM CaCl2, without EGTA/EDTA, or 1 mM
EGTA/EDTA, without CaCl2, respectively).
Table 1
Percentage of iNOS- and eNOS-immunostained nuclei in brown fat
of rats kept at room temperature (22‡C) or acclimated to cold for
3 or 14 days, or treated with CL 316,243 (1 mg/kg/day, i.p.) for
1 week
22‡C 4‡C (3 days) 4‡C (14 days) CL 316,243
iNOS 9 þ 1 21 þ 3* 43 þ 3* 54 þ 4*
eNOS 32 þ 3 30 þ 2 48 þ 3* 63 þ 2*
*P6 0.005 vs. untreated rats acclimated to room temperature.
Fig. 4. BAT iNOS immunohistochemistry (polyclonal antibody,
1:500) in obese rats. In normal-weight (+/fa) rats (A), numerous
brown adipocytes show nuclear staining; in obese (fa/fa) rats (B),
few brown fat cells show a weak nuclear staining. Bar, 20 Wm.
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and eNOS) was more intense in the animals acclimated to
cold for 3 or 14 days or treated with CL 316,243 than in those
kept at room temperature (not shown), suggesting that, in
addition to increasing their expression, noradrenergic stimu-
lation enhances the functional activity of the two nuclear NOS
isoforms. This ¢nding was supported by in vitro experiments:
the exposure of cultured brown adipocytes to 1 WM NA for 24
h increased the nuclear activities of both eNOS (10 WM CaCl2,
without EGTA/EDTA) (40% above the baseline) and iNOS (1
mM EGTA/EDTA, without CaCl2) (35% above the baseline)
as measured by conversion of L-[3H]arginine to L-[3H]citrulline
(Fig. 3B).
Finally, Western blotting analyses showed that eNOS ex-
pression signi¢cantly increased in the PNS and nuclear frac-
tions of the cells treated with NA (1 WM; 24 h) or TNF-K (10
nM; 24 h) compared with untreated cells (Fig. 1B, lanes 4^9).
4. Discussion
Brown adipocytes are endowed with NOS enzymes [10]. As
it di¡uses over the vascular bed, NO is likely involved in the
cold-induced matching of BAT thermogenesis/vasodilation
[9,10]. In addition, NO has been shown to improve the di¡er-
entiation of cultured brown adipocytes [24] and to a¡ect the
respiratory rate of isolated BAT mitochondria [25] by an au-
tocrine action. The present results show that eNOS and iNOS
are located not only in the cytoplasm but also in the nucleus
of brown adipocytes, where their amount and functional ac-
tivities are dynamically modulated by noradrenaline. This en-
tails that NO can be directly produced in the nucleus of these
cells.
Interestingly, serial BAT sections from animals acclimated
to cold for two di¡erent periods showed that both cytoplasmic
and nuclear eNOS and iNOS are expressed, or more intensely
expressed, in the same brown adipocytes that are positive, or
more intensely positive, for UCP1 (unpublished observations).
Thus, NOS expression in brown adipocytes is positively cor-
related with cellular activation and heat production.
We have recently reported that treatment of cultured brown
fat cells with NO-generating S-nitroso-L-glutathione (300 WM;
60 min) increases the expression of the genes involved in
brown fat cell di¡erentiation and function, including peroxi-
some proliferator-activated receptor Q-2, UCP1 [24] and c-fos
(unpublished data). Thus, a possible function of NO produced
directly in the nucleus may be the modulation of gene expres-
sion. Indeed, an action of NO on gene expression has been
well documented in several cell types, via cytoplasmic activa-
tion of transduction pathways such as cGMP [26] and calcium
[27]. However, NO is an extremely reactive and unstable mol-
ecule in biological systems. Its steady-state concentration ^ on
which its biological e¡ects depend ^ is critically determined
not only by its rate of production but also by its rate of
decomposition, the latter being closely related to microenvi-
ronmental redox conditions [28]. Brown adipocytes are unique
cells in this regard: when stimulated by NA, the rapid induc-
tion of UCP1 uncouples oxidative phosphorylation, with a
concomitant increase in metabolic rate and fat utilization.
Increased free radical generation due to raised fatty acid oxi-
dation, relative hypoxemia, and heat production subject
brown adipocytes to a metabolic stress that may create an
environment ‘hostile’ to the action of NO. The localization
or migration of the NOS isoforms into the nucleus might
provide a subcellular environment more suitable than cytosol
for a more speci¢c and e¡ective action of NO-producing sys-
tems, and for their close control. It would not be surprising if
a similar control of NO signaling also intervened in other cell
types under physiological or pathophysiological conditions.
Of note, the presence of nuclear NOS has been demonstrated,
albeit not conclusively, in cultured neonatal rat cardiomyo-
cytes [29], glandular elements of normal and carcinomatous
human endometrium [30], and pancreatic L-cells [31].
Finally, we have recently reported that the isoforms of
heme oxygenase (HO) ^ a ubiquitous microsomal enzyme
that produces carbon monoxide (CO), a novel gaseous medi-
ator [32] ^ are detectable in both the nucleus and cytosol of
rat brown adipocytes and that inducible HO-1 (but not con-
stitutive HO-2) is up-regulated in the nucleus following cold
exposure [33] and down-regulated in genetic obesity (unpub-
lished data).
The present data, together with the research previously car-
ried out by our group [10,24,33], suggest that brown adipo-
cytes contain noradrenergically modulated nuclear enzyme
systems able to produce biologically active gaseous mediators
such as NO and CO, which could cooperate in controlling
brown fat cell biology.
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